Two starting points. One decision standard.

A healthcare company had invested in the science, testing, reports, onboarding resources, and operating infrastructure behind a complex offering.

The offering had several possible buyers, clinical applications, partnerships, and growth paths. Interest existed, but interest and onboarding were not consistently becoming meaningful use. Pursuing more buyers or broader distribution would not resolve the underlying question of fit.

• •Which patient population would benefit most
• •Which buyer had the strongest reason to act
• •Where the offering belonged in care
• •How patients would be identified, ordered, tested, supported, and followed
• •What providers and staff would need to understand and do
• •Who owned each handoff across the full pathway
• •Whether delivery time, operations, authority, and economics could support adoption
• •What evidence would justify broader investment

The assessment found that the innovation may create meaningful value, but the proposed commercial path was not ready to move forward under the current conditions.

The initial use case, delivery path, operating evidence, ownership, economics, decision authority, and external role had not been aligned well enough to justify further investment. The right decision was to step back before more activity created more cost without a dependable path to adoption or revenue.

The determination did not reject the opportunity. It preserved the opportunity until the conditions required for a focused engagement could be established.

The value was not limited to finding an opportunity. It included preventing the wrong work.

By identifying the misalignment early, True Myth protected both organizations from spending more time, money, relationships, and operating capacity on acquisition, commercial support, internal coordination, partnership activation, and infrastructure that the current path was not ready to support.

The assessment also preserved option value. Instead of allowing the relationship to deteriorate through unclear expectations or failed execution, it documented what did not fit, what would need to change, and what evidence would justify reengagement. The relationship remained transparent, useful, and capable of creating future value.

• •A clear fit determination
• •A documented explanation of what did and did not currently fit
• •Visibility into the work and investment that would otherwise occur before revenue
• •The evidence and operating conditions required for reengagement
• •A possible bounded pathway if those conditions are met
• •Clearer expectations around scope, authority, ownership, and economics
• •A transparent record that protects trust and preserves the relationship

• ✓One defined use case and priority population
• ✓A dependable delivery path
• ✓Measured operating evidence from real use
• ✓A clear internal owner with decision authority
• ✓Verified channel and engagement economics
• ✓A bounded external role with aligned scope, access, authority, time, and compensation

A specialty practice delivers a trusted, high-touch clinical service. Through direct experience with patients, the physician sees that a defined group of women in midlife may need more continuity, education, and support before, during, and after an isolated clinical encounter.

The physician wants to spend more time doing the relational work that makes the practice distinct. The goal is not simply more volume. It is a more intentional patient experience and a business model capable of supporting it.

The opportunity is promising, but it is not yet a program. The priority population, patient need, pathway boundaries, workflow, ownership, economics, compliance requirements, and measures of success still need to be determined.

• •What the physician wants to strengthen, what should change, and what is worth building around
• •Which patient population should be prioritized
• •What those patients need, value, trust, access, and use
• •What belongs inside the pathway and what does not
• •What must remain physician-directed clinical care
• •Which responsibilities can be supported by the broader team
• •How patients move through the experience from identification through follow-up
• •Where outside services, innovations, or relationships may strengthen the pathway
• •Whether staffing, workflow, capacity, compliance, and economics can support it
• •What evidence would support building, strengthening, or redirecting the path

True Myth would begin with the physician’s goals and the priority patient population, not with a product, modality, membership concept, new location, or predetermined solution.

The Model would determine whether the observed need is strong and specific enough to support a focused pathway, what the practice should own, where outside services, innovations, or relationships may fit, how responsibility should move across the experience, and whether the opportunity is viable enough to test.

If the opportunity does not fit the physician’s goals, clinical boundaries, team capacity, patient demand, or economics, the recommendation may be to strengthen or redirect the opportunity rather than build something new.

If fit is established, the first step would not be a broad launch. It would be a bounded validation effort designed to answer the most important questions before the practice makes a larger investment.

• •A defined priority population
• •Clear pathway and clinical boundaries
• •A patient journey and operating workflow
• •Internal and external ownership
• •Required services and relationships
• •Economic and operating requirements
• •A bounded validation plan
• •Success measures and a clear next decision

The practice can test the opportunity before investing heavily in new space, staffing, services, marketing, or infrastructure.

The pathway can protect the physician’s time for the work only the physician should own, while making the rest of the patient experience more coherent and operationally supportable.

The result is not more activity for its own sake. It is evidence the practice can use to decide whether the broader opportunity deserves to be built.

Clinical decisions, eligibility, consent, safety, and care remain with licensed professionals.